Advertisement
Research Article| Volume 14, ISSUE 2, P329-338, April 01, 1998

NOSOCOMIAL DIARRHEA

  • Author Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
    Burke A. Cunha
    Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
    Search for articles by this author
  • Author Footnotes
    * From the Infectious Disease Division, Winthrop-University Hospital, Mineola; and the State University of New York School of Medicine, Stony Brook, New York
      Diarrhea that occurs in hospitalized patients may be due to an infectious or noninfectious cause. Noninfectious causes include alterations of the patient's flora by changes in diet or medications or changes in the osmolarity of bowel contents. Some antibiotics cause diarrhea on an irritative basis or by changes in the normal bowel flora. Erythromycin is poorly absorbed and consequently often results in an irritative diarrhea. Amoxicillin/clavulanic acid frequently results in gastrointestinal upset as well as a diarrhea caused by the clavulanic acid component of this antibiotic combination. Ceftriaxone significantly alters the flora in individuals and causes diarrhea in up to 50% of children; it causes diarrhea in adults, but less frequently.
      An important cause of diarrhea in the critical care setting occurs in patients on enteral alimentation. Enteral feeds may cause diarrhea by interfering with the patient's flora, overwhelming normal fluid exchange mechanisms in the gut, or by altering the osmolarity of bowel contents. Isolosmolar enteral fluids are least likely to result in diarrhea. Furthermore, diarrhea may be caused simply by high infusion rates, even when using isosmotic solutions. The gastrointestinal tract in a patient in the critical care unit (CCU) often is not functioning normally for a variety of reasons. Many of these patients have ileus or an atonic bowel that cannot tolerate the large fluid loads presented to it by overzealous enteral feedings.
      • Caines C.
      • Gill M.V.
      • Cunha B.A.
      Non- Clostridium difficile nosocomial diarrhea in the intensive care unit.
      • Yannelli B.
      • Gurevich I.
      • Schoch P.E.
      • et al.
      Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas.
      The infectious causes of diarrhea in the hospital are most commonly due to Clostridium difficile in contrast to community-acquired diarrheal pathogens (i.e., entero-, toxogenic, and enteropathogenic Escherichia coli, Shigella, Salmonella, Yersinia, and Campylobacter). Community-acquired diarrheas also may be due to viruses, especially in children, and adults may have diarrhea due to intestinal protozoa (i.e., amoebas, cryptosporidia, or cyclospora). These community-acquired diarrhea pathogens usually do not cause nosocomial diarrhea, except in an outbreak situation. Such outbreaks are clearly recognizable because of the clustering of diarrhea due to the same organism in specific locations in the hospital. If nosocomial diarrhea is on an infectious basis, the clinician should view it as being due to C. difficile. There is no need to culture specimens for the usual enteric pathogens or to examine patients' stools for ova and parasites. This is not a cost-effective procedure and is to be discouraged.
      • Bartlett J.G.
      Clostridium difficile: Clinical considerations.
      • Fekety R.
      • Kim K.H.
      • Brown D.
      • et al.
      Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment.
      • Fekety R.
      • Shah A.B.
      Diagnosis and treatment of Clostridium difficile colitis.
      • Gerding D.N.
      • Olson M.M.
      • Peterson L.R.
      • et al.
      Clostridium difficile-associated diarrhea and colitis in adults: A prospective case-controlled epidemiologic study.
      • Gerding D.N.
      • Olson M.M.
      • Johnson S.
      • et al.
      Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole.
      • Gerding D.N.
      • Brazier J.S.
      Optimal methods for identifying Clostridium difficile infections.
      • Malamou-Ladas H.
      • Farrell S.O.
      • Nash J.O.
      • et al.
      Isolation of Clostridium difficile from patients and the environment of hospital wards.
      • Peterson L.R.
      • Kelly P.J.
      The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea.
      • Yannelli B.
      • Gurevich I.
      • Schoch P.E.
      • et al.
      Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas.
      C. difficile diarrhea is diagnosed by demonstrating C. difficile toxin assay in stool specimens. Stools often remain C. difficile toxin-positive after clinical resolution of the patient's diarrhea, and positivity may persist for some time. Ordinarily, treatment is stopped and enteric precautions discontinued after cessation of the diarrhea. The most severe clinical expression of C. difficile is pseudomembranous colitis, a dreaded complication of C. difficile diarrhea that may result in toxic megacolon. Colon perforation is a complication of toxic megacolon that may result in death.
      • Bartlett J.G.
      Clostridium difficile: Clinical considerations.
      • Fekety R.
      • Shah A.B.
      Diagnosis and treatment of Clostridium difficile colitis.
      • MacLaren R.
      • Morton T.H.
      • Kuhl D.A.
      Effective management of Clostridium difficile colitis.
      Infection control practices are important in limiting the spread of C. difficile spores within the hospital. C. difficile spores are highly resistant to adverse environmental conditions and persist in the hospital for extended periods.
      • Kerr R.B.
      • McLaughlin D.I.
      • Sonnenberg I.W.
      Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole.
      • Kim K.H.
      • Fekety R.
      • Batts D.H.
      • et al.
      Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bartlett J.G.
        Clostridium difficile: Clinical considerations.
        Rev Infect Dis. 1990; 12: S243
        • Caines C.
        • Gill M.V.
        • Cunha B.A.
        Non- Clostridium difficile nosocomial diarrhea in the intensive care unit.
        Heart Lung. 1997; 26: 83
        • Fekety R.
        • Kim K.H.
        • Brown D.
        • et al.
        Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment.
        Am J Med. 1981; 70: 906
        • Fekety R.
        • Shah A.B.
        Diagnosis and treatment of Clostridium difficile colitis.
        JAMA. 1993; 269: 71
        • Gerding D.N.
        • Olson M.M.
        • Peterson L.R.
        • et al.
        Clostridium difficile-associated diarrhea and colitis in adults: A prospective case-controlled epidemiologic study.
        Arch Intern Med. 1986; 146: 95
        • Gerding D.N.
        • Olson M.M.
        • Johnson S.
        • et al.
        Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole.
        Am J Surg. 1990; 159: 212
        • Gerding D.N.
        • Brazier J.S.
        Optimal methods for identifying Clostridium difficile infections.
        Clin Infect Dis. 1993; 16: S439
        • Kerr R.B.
        • McLaughlin D.I.
        • Sonnenberg I.W.
        Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole.
        Am J Infect Control. 1990; 18: 332
        • Kim K.H.
        • Fekety R.
        • Batts D.H.
        • et al.
        Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.
        J Infect Dis. 1981; 143: 42
        • MacLaren R.
        • Morton T.H.
        • Kuhl D.A.
        Effective management of Clostridium difficile colitis.
        Hosp Pharm. 1997; 32: 1126
        • Malamou-Ladas H.
        • Farrell S.O.
        • Nash J.O.
        • et al.
        Isolation of Clostridium difficile from patients and the environment of hospital wards.
        J Clin Pathol. 1983; 6: 88
        • Peterson L.R.
        • Kelly P.J.
        The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea.
        Infect Dis Clin North Am. 1993; 7: 277
        • Yannelli B.
        • Gurevich I.
        • Schoch P.E.
        • et al.
        Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas.
        Am J Infect Control. 1988; 16: 246